This information
collection is approved for use through 4/94. Though OMB is
approving this information collection as requested by AHCPR, it is
approving it with severe reservations as to the practical utility o
this particular effort and its overall usefulness in the context of
AHCPR's general evaluation strategy for practice guidelines. In
particular, OMB believes that severe design limitations prevent
this effort from achieving AHCPR's statutory research mission. The
four State sites (Michigan, Pennsylvania, Alabama, and
Massachusetts) and participating PROs are inadequate in number and
characteristics to control for potential confounding effects from
variables such as different educational intervention strategies,
patient demographics, local medical practices, and unique PRO
management styles. Consequent it does not support needed inferences
concerning dissemination practic or the guidelines themselves, and
it does not permit valid generalization of findings to other
States, PROs, physicians or patien populations nationwide. In
addition, the relatively small patient and physician sample sizes
provide the statistical power to recognize only large differences
in response. OMB strongly recommends that prior to fielding these
instruments, AHCPR increases the number of States, PROs and sites
in the study, and at a minimum analyzes Medicare Part A and claims
files before and after dissemination, in order to better under-
stand guidelines use in the context of utilization and patient
outco
Inventory as of this Action
Requested
Previously Approved
04/30/1994
04/30/1994
1,038
0
0
492
0
0
0
0
0
DATA ARE NEEDED TO EVALUATE PHYSICIAN
AND PATIENT AWARENESS OF AND ATTITUDES TOWARD AHCPR-SPONSORED
GUIDELINES FOR BENIGN PROSTATIC HYPERPLASIA (BPH) AND QUALITY AND
UTILIZATION REVIEW CRITERIA BASED ON THE GUIDELINES. PHYSICIANS AND
THEIR PATIENTS WILL BE SURVEYED
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
PHYSICIAN AND PATIENT SURVEYS TO EVALUATE THE AHCPR SPONSORED CLINICAL PRACTICE GUIDELINE FOR BENIGN PROSTATIC HYPERPLASIA